1. Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma
   Emily Capone et al, 2017, Oncotarget CrossRef
2. Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies
   Daniel J. O’Shannessy et al, 2016, Sarcoma CrossRef
3. A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors
   Toshihiko Doi et al, 2019, Investigational New Drugs CrossRef